Vista Pharmaceuticals Ltd share price logo

Vista Pharmaceuticals Ltd Share Price

9.83

-0.27

(-2.67%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Vista Pharmaceuticals Ltd Stock Performance

as on September 8, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹9.36
    ₹10.14
    downward going graph

    4.78%

    Downside

    3.15%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹9.1
    ₹14.85
    downward going graph

    7.43%

    Downside

    51.07%

    Upside

    downward going graph

Vista Pharmaceuticals Ltd share price movements today

Previous Close
₹10.10
Open
₹10.09
Volume
6,537.00
Upper Circuit
₹11.11
Lower Circuit
₹9.09
Day's Low - High
₹9.36 - ₹10.14
52 Week Low - High
₹9.1 - ₹14.85

Vista Pharmaceuticals Ltd Historical Returns

1 Month Return
-6.91 %
3 Month Return
-14.77 %
1 Year Return
-23.31 %
3 Year Return
+ 13.61 %
5 Year Return
+ 8.49 %

Vista Pharmaceuticals Ltd Fundamentals

as on September 8, 2025 at 4:01 pm IST

Market Cap

₹62.17 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Beta (LTM)

0.63

P/B Ratio

1.41

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

50

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Vista Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vista Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA62.171.7%0.00-510
NA69.883.03%0.00133
NA44.49-17.01%0.00-22104
NA120.6659.56%0.001495
NA162.3498.3%0.006113

Vista Pharmaceuticals Ltd Stock's Interest Amongst Investors

Search interest for Vista Pharmaceuticals Ltd Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

Vista Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
-
-
-
1.98
3.47
1.7
3.13
1.8
2.49
2.56
3.23
1.52
Other Income
-
-
-
0.13
0.08
0.02
0.1
0.07
0.01
0.12
0.24
-
Total Income
-
-
-
2.11
3.55
1.73
3.23
1.87
2.5
2.68
3.47
1.52
Expenses
0.15
0.33
0.21
2.9
4.64
3.45
2.87
2.57
3.32
4.07
4.14
2.63
Operating Profit
-0.15
-0.33
-0.21
-0.92
-1.17
-1.75
0.26
-0.77
-0.83
-1.51
-0.91
-1.11
Operating Profit Margin %
0%
0%
0%
-46.46%
-33.72%
-102.94%
8.31%
-42.78%
-33.33%
-58.98%
-28.17%
-73.03%
Profit Before Interest, Tax and Depreciation
-0.15
-0.33
-0.21
-0.79
-1.09
-1.72
0.36
-0.71
-0.82
-1.39
-0.67
-1.11
Interest
0.26
0.4
0.26
0.33
0.32
0.3
0.28
0.28
0.25
0.22
0.21
0.19
Depreciation
0.15
0.15
0.15
0.17
0.18
0.18
0.18
0.18
0.18
0.19
0.18
0.18
Profit Before Tax
-0.56
-0.88
-0.62
-1.29
-1.59
-2.2
-0.1
-1.17
-1.25
-1.8
-1.06
-1.48
Tax Paid
-0.32
0.07
-0.32
-0.33
0.43
-0.57
-0.19
-0.31
-0.28
-0.48
0.43
-0.19
Profit After Tax
-0.24
-0.96
-0.3
-0.95
-2.02
-1.63
0.09
-0.86
-0.97
-1.32
-1.5
-1.29
Total Net profit including share of profit / Loss from associate company
-0.24
-0.96
-0.3
-0.95
-2.02
-1.63
0.09
-0.86
-0.97
-1.32
-1.5
-1.29
EPS
-0.08
-0.27
-1
-0.23
-0.46
-0.33
0.02
-0.15
-0.16
-0.07
-0.79
-0.22
Actual EPS
-0.08
-0.27
-1
-0.23
-0.46
-0.33
0.02
-0.15
-0.16
-0.07
-0.79
-0.22
Adjusted EPS
-0.08
-0.27
-1
-0.23
-0.46
-0.33
0.02
-0.15
-0.16
-0.07
-0.79
-0.22
Diluted EPS
-0.08
-0.27
-0.59
-0.15
-0.34
-0.26
0.01
-0.15
-0.17
-0.07
-0.79
-0.22

Vista Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
24.18
28.92
31.07
22.76
1.27
0.39
1
10.29
10.07
Other Income
0.06
0.4
2.95
3.75
0.2
0.17
0.4
0.33
0.44
Total Income
24.24
29.31
34.02
26.51
1.46
0.56
1.4
10.62
10.52
Expenses
21.13
23.58
29.84
27.56
3
1.61
5.45
13.86
14.1
Operating Profit
3.05
5.34
1.23
-4.8
-1.73
-1.22
-4.45
-3.57
-4.03
Operating Profit Margin %
12.61%
18.46%
3.96%
-21.09%
-136.22%
-312.82%
-445%
-34.69%
-40.02%
Profit Before Interest, Tax and Depreciation
3.11
5.74
4.18
-1.05
-1.53
-1.04
-4.05
-3.24
-3.59
Interest
0.88
1.57
1.67
1.54
1.55
0.9
1.21
1.22
0.96
Depreciation
1.02
1.34
1.36
1.35
0.73
0.62
0.62
0.72
0.74
Profit Before Tax
1.21
2.83
1.15
-3.94
-3.81
-2.56
-5.88
-5.18
-5.29
Tax Paid
-0.02
0.64
0.21
-0.26
-1.8
-1.73
-0.21
-0.67
-0.64
Profit After Tax
1.25
2.19
0.94
-3.68
-2.01
-0.83
-5.66
-4.51
-4.65
Total Net profit including share of profit / Loss from associate company
1.25
2.19
0.94
-3.68
-2.01
-0.83
-5.66
-4.51
-4.65
EPS
0.46
0.76
0.76
-1.22
-0.54
-0.24
-1.54
-1.03
-0.79
Actual EPS
0.46
0.76
0.76
-1.22
-0.54
-0.24
-1.54
-1.03
-0.79
Adjusted EPS
0.46
0.76
0.76
-1.22
-0.54
-0.24
-1.54
-1.03
-0.79
Diluted EPS
0.46
0.73
0.73
-1.22
-0.54
-0.24
-0.9
-0.74
-0.79

Vista Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
-3.53
-2.5
2.57
-4.58
3.3
0.8
-6.75
-0.99
-1.71
-4.91
Cash Flow from Investing Activities
-0.09
-0.24
-3.61
-10.61
-5.65
-1.73
-0.3
-0.01
-1.27
-0.79
Cash Flow from Financing Activities
3.63
3.07
6.35
11.22
1.43
0.28
6.96
0.93
3.11
5.6
Net Cash Flow
-
0.34
5.32
-3.98
-0.92
-0.64
-0.09
-0.07
0.13
-0.11

Vista Pharmaceuticals Ltd Stock Shareholding Pattern

Numbers in percentages

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
35.44%
35.44%
35.44%
30.49%
29.51%
27.81%
27.81%
21.19%
21.19%
21.19%
21.19%
21.19%
DII
0.04%
0.04%
0.04%
0.03%
0.03%
0.03%
0.03%
0.02%
0.02%
0.02%
0.02%
0.02%
Public
64.52%
64.52%
64.52%
69.48%
70.46%
72.16%
72.16%
78.79%
78.79%
78.79%
78.79%
78.79%
Total Outstanding Shares
3,67,93,907
3,67,93,907
3,67,93,907
4,27,67,073
4,41,91,566
4,68,98,232
4,68,98,232
6,15,51,907
6,15,51,907
6,15,51,907
6,15,51,907
6,15,51,907
Total Shareholders
14,689
14,912
14,796
14,648
14,250
13,908
14,015
13,882
13,913
14,086
14,158
14,061

Vista Pharmaceuticals Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Vista Pharmaceuticals Ltd.

  • Vista Pharmaceuticals Ltd Earnings Results

    Vista Pharmaceuticals Ltd’s net profit fell -50% since last year same period to ₹-1.29Cr in the Q1 2025-2026. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated 14% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Vista Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 16.2% return, outperforming this stock by 39.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.1% return, outperforming this stock by 123.5%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 78.79% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 21.19% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, Vista Pharma. stock has moved down by -6.9%

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Limited is an India-based pharmaceutical company engaged in the formulation of pharmaceutical products catering to common ailments. The company was incorporated in 1991 with its capital subscribed by Vista Pharmaceuticals Inc. from the State of New Jersey, USA. In 2010, the company obtained approval from the US Food and Drug Administration, and produced 20.488 million numbers of tablets. Vista Pharmaceuticals Limited is in the process of setting up a 100 EOU for the manufacture of drug formulations with an installed capacity of 400 million tablets and 200 million capsules per annum. With a wide range of products, efficient processes and plans for expansion, the company is well-positioned to deliver quality pharmaceutical solutions to customers in India and beyond.

Revenue: ₹1.52Cr as on June 2025 (Q1 FY26)
Net Profit: ₹-1.29Cr as on June 2025 (Q1 FY26)
Chairperson Name: Dhananjaya Alli
OrganisationVista Pharmaceuticals Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEODhananjaya Alli
E-voting on sharesClick here to vote

FAQs

What is Vista Pharmaceuticals Ltd share price today?

Vista Pharmaceuticals Ltd share price today stands at ₹9.83 as on at the close of the market. Vista Pharmaceuticals Ltd share today touched a day high of ₹10.14 and a low of ₹9.36.

What is the 52 week high and 52 week low range for Vista Pharmaceuticals Ltd share?

Vista Pharmaceuticals Ltd touched a 52 week high of ₹14.85 and a 52 week low of ₹9.1. Vista Pharmaceuticals Ltd share price today i.e. is closed at ₹9.83, which is -33.80% down from its 52 week high and 8.02% up from its 52 week low.

What is Vista Pharmaceuticals Ltd's market capitalisation today?

Vista Pharmaceuticals Ltd market capitalisation is ₹62.17 Cr as on .

How to buy Vista Pharmaceuticals Ltd shares?

To buy Vista Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524711 or Vista Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Vista Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Vista Pharmaceuticals Ltd trading volume today?

Vista Pharmaceuticals Ltd trading volume is 6,537.00 as on . This means that 6,537.00 shares of Vista Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.